Cardiac complications after stem cell transplantation.
Cardiac insufficiency / toxicity has been recognized as a complication of intensive cytotoxic therapy used in stem cell transplant setting. The incidence of clinically significant cardiac toxicity following high dose chemotherapy ranges between 2 - 43% with mortality of 2 - 9%. Two patients are reported who developed life-threatening cardiac complications following cyclophosphamide and busulphan therapy requiring pericardiocentesis and pericardiectomy.
Department of Haematology, AFBMTC, Rawalpindi.
Tariq Mahmood
TM
Satti
Khalil
K
Ullah
Pervez
P
Ahmed
Shahid
S
Raza
Qamar-Un- Nisa
QU
Chaudhry
Aamer
A
Ikram
Muhammad Khalid
MK
Kamal
Furrukh Mahmood
FM
Akhtar